Zobrazeno 1 - 10
of 110
pro vyhledávání: '"William P. Forbes"'
Autor:
Leonard B. Weinstock, Philip Schoenfeld, Craig Paterson, Satish S.C. Rao, Anthony Lembo, William P. Forbes, Brooks D. Cash, Mark Pimentel, Enoch Bortey
Publikováno v:
Gastroenterology. 151(6):1113-1121
Background & Aims Few treatments have demonstrated efficacy and safety for diarrhea-predominant irritable bowel syndrome (IBS-D). A phase 3, randomized, double-blind, placebo-controlled trial was performed to evaluate the safety and efficacy of repea
A Fast and Frugal Finance: Bridging Contemporary Behavioural Finance and Ecological Rationality adds psychological reality to classical financial reasoning. It shows how financial professionals can reach better and quicker decisions using the'fast an
Autor:
Craig Paterson, Robert J. Israel, William P. Forbes, Andrew C. Barrett, Charles V. Wellman, Janet Bull
Publikováno v:
Journal of Palliative Medicine
Background: Subcutaneous methylnaltrexone (MNTX), dosed based on body weight, is efficacious and well tolerated in inducing bowel movements in patients with advanced illness and opioid-induced constipation (OIC); however, fixed-dose administration of
Autor:
Craig Paterson, Joseph V. Pergolizzi, Jing Yu, Srinivas Nalamachu, Robert W. Taylor, William P. Forbes, Enoch Bortey, Andrew C. Barrett, Neal E. Slatkin
Publikováno v:
Pain Practice. 15:564-571
Background Subcutaneous methylnaltrexone is efficacious and well tolerated in inducing bowel movements in patients with advanced illness and opioid-induced constipation (OIC); factors determining optimal responsiveness to OIC treatment, however, have
Autor:
Jeffrey Axler, Cindy Zhu, Gary R. Lichtenstein, William P. Forbes, Andrew C. Barrett, Robert H. Riddell, William J. Sandborn, Russell D. Cohen, David T. Rubin, Enoch Bortey
Publikováno v:
Journal of Crohn's & Colitis
Background and Aims: Safety and efficacy of budesonide multimatrix, an oral extended-release second-generation corticosteroid designed for targeted delivery throughout the colon, were examined for induction of remission in patients with mild to moder
Autor:
G. L. Gordon, Kunal Merchant, S. Sedghi, Uma K. Murthy, Salam Zakko, Gary R. Lichtenstein, William P. Forbes, Enoch Bortey, Ronald E. Pruitt
Publikováno v:
Alimentary Pharmacology & Therapeutics. 36:126-134
Summary Background Mesalazine (mesalamine) granules (MG) were shown to be effective for the maintenance of remission of ulcerative colitis (UC) in two double-blind placebo-controlled trials. Aim To evaluate the efficacy of once-daily MG for maintenan
Publikováno v:
Regional anesthesia and pain medicine. 41(1)
Background and Objectives In patients with chronic noncancer pain, subcutaneous methylnaltrexone for opioid-induced constipation (OIC) was examined in a randomized controlled trial (RCT) followed by an open-label extension (OLE). This study examined
Autor:
Zobair M. Younossi, Kevin D. Mullen, Shirley Huang, Enoch Bortey, Nathan M. Bass, M. Mazen Jamal, William P. Forbes, Ravikumar Vemuru, Robert S. Brown, Kunal Merchant, Arun J. Sanyal, Fred Poordad
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:853-861
Aliment Pharmacol Ther 2011; 34: 853–861 Summary Background Hepatic encephalopathy (HE) is a brain disorder that often results from cirrhosis due to viral hepatitis, metabolic and alcohol-related liver disease, and is characterised by cognitive, ps
Autor:
Uma K. Murthy, G. L. Gordon, Audrey L. Shaw, Enoch Bortey, Ronald E. Pruitt, Gary R. Lichtenstein, S. Sedghi, William P. Forbes, Kunal Merchant, Salam Zakko
Publikováno v:
Alimentary Pharmacology & Therapeutics. 32:990-999
Aliment Pharmacol Ther 2010; 32: 990–999 Summary Background Ulcerative colitis (UC) is a chronic relapsing and remitting idiopathic inflammatory bowel disorder. Aim To evaluate once-daily mesalamine (mesalazine) granules (MG) for maintenance of rem
Autor:
Darren M. Brenner, Craig Paterson, William P. Forbes, Andrew C. Barrett, Lynn R Webster, Enoch Bortey
Publikováno v:
Journal of Pain Research
Subcutaneous methylnaltrexone is efficacious and well tolerated for opioid-induced constipation (OIC) but may theoretically disrupt opioid-mediated analgesia.Opioid use, pain intensity, and opioid withdrawal (Objective Opioid Withdrawal Scale [OOWS]